Ketone Bodies and Ketogenesis

Why ketone bodies matter

• They let humans survive starvation. The brain normally consumes about 120 grams of glucose a day, and total body glycogen — liver plus muscle — holds only about 400 to 500 grams, enough for roughly a day. Without ketones, prolonged fasting would force the body to shred muscle protein for gluconeogenesis at a lethal rate. By week three of a fast, ketone bodies supply up to two-thirds of the brain's energy, cutting the daily glucose requirement and its protein cost roughly in half.
• They are a heart and muscle fuel too. Cardiac muscle and the renal cortex readily oxidize acetoacetate and beta-hydroxybutyrate; the heart in particular prefers ketones and fatty acids over glucose. In heart failure the failing myocardium upregulates ketone oxidation, and the glucose-lowering SGLT2-inhibitor drugs are thought to benefit failing hearts partly by nudging metabolism toward ketones.
• Beta-hydroxybutyrate is a signaling molecule. Beyond fuel, BHB inhibits class I histone deacetylases (HDACs), activates the receptor HCAR2/GPR109A, and blocks the NLRP3 inflammasome. These actions are being investigated for effects on inflammation, longevity, and neuroprotection — ketones are not just an energy source but a metabolic message.
• The ketogenic diet is an established epilepsy therapy. Formalized at the Mayo Clinic in 1921 by Russell Wilder, the classic 4:1 ketogenic diet still halves seizures in roughly half of children with drug-resistant epilepsy and is first-line for GLUT1 deficiency syndrome, where glucose cannot enter the brain.
• Uncontrolled, they are lethal. In type 1 diabetes with no insulin, ketogenesis runs away into diabetic ketoacidosis — a leading cause of death in young people with diabetes before insulin therapy, and still a life-threatening emergency today.
• They are exhaled and smelled. Acetone is volatile and leaves in the breath, giving deep ketosis and DKA a distinctive sweet, fruity, nail-polish-remover odor — a bedside diagnostic clue for centuries.

Common misconceptions

• "Ketones are a starvation toxin." Acetoacetate and beta-hydroxybutyrate are ordinary metabolic fuels, oxidized cleanly to CO₂ and water and yielding ATP. They only become dangerous when their concentration is high enough to acidify the blood — a problem of quantity and missing insulin, not of the molecules themselves.
• "Ketosis and ketoacidosis are the same thing." Nutritional ketosis (about 0.5 to 3 mmol/L, normal pH) and diabetic ketoacidosis (above 10 to 25 mmol/L, pH below 7.30) differ roughly ten-fold in ketone level and are physiologically opposite: ketosis is insulin-restrained and self-limiting, DKA is insulin-absent and runaway.
• "Beta-hydroxybutyrate is a ketone." Chemically it is a hydroxy acid — its would-be ketone carbon has been reduced to a hydroxyl. It is counted among the ketone bodies only because it interconverts with acetoacetate, the true ketone. This is why the classic nitroprusside urine strip, which detects acetoacetate and acetone but not BHB, can badly underestimate total ketones.
• "The liver runs on the ketones it makes." Hepatocytes are the sole major site of ketogenesis but cannot oxidize ketone bodies at all, because they lack SCOT (succinyl-CoA:3-ketoacid CoA transferase, OXCT1), the enzyme that reactivates acetoacetate to acetoacetyl-CoA. The liver is a selfless factory: it builds the fuel and ships all of it to other organs.
• "Ketogenesis and cholesterol synthesis are the same HMG-CoA pathway." Both use an HMG-CoA intermediate, but in different compartments and with different enzymes. Ketogenesis uses mitochondrial HMGCS2 and HMG-CoA lyase; cholesterol synthesis uses cytosolic HMGCS1 and HMG-CoA reductase — the statin target. Sharing a molecule name is not sharing a pathway.
• "Ketones only appear on a fad diet." Everyone makes ketones every night. After an overnight fast, blood ketones rise measurably; they are a normal, continuous part of energy metabolism, not an exotic diet-only state.

How ketogenesis works, step by step

Ketogenesis is switched on by hormones and executed inside liver mitochondria. When blood glucose falls, insulin drops and glucagon rises. Low insulin unleashes lipolysis in adipose tissue: hormone-sensitive lipase and ATGL release free fatty acids into the blood, which travel bound to albumin to the liver. There, fatty acids are activated to fatty acyl-CoA and carried into the mitochondrial matrix by the carnitine shuttle (CPT1, the rate-limiting step of fatty-acid entry). Falling malonyl-CoA — a consequence of the same low-insulin state — releases CPT1 from inhibition, so fat pours into the mitochondrion.

Inside, beta-oxidation chops each fatty acyl-CoA two carbons at a time into acetyl-CoA. In the fed state this acetyl-CoA would enter the citric acid cycle by condensing with oxaloacetate. But during fasting, oxaloacetate is siphoned away into gluconeogenesis, so the cycle backs up and acetyl-CoA accumulates. That surplus is the raw material for ketone bodies. The classic aphorism — "fat burns in the flame of carbohydrate" — captures the fact that without enough oxaloacetate, acetyl-CoA is diverted from the cycle into ketogenesis.

The HMG-CoA pathway then runs in four moves. (1) Two molecules of acetyl-CoA condense to acetoacetyl-CoA, catalyzed by mitochondrial thiolase (T2) running in its synthetic direction. (2) A third acetyl-CoA is added by mitochondrial HMG-CoA synthase (HMGCS2) to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA); HMGCS2 is the rate-limiting, hormonally regulated enzyme, induced by glucagon, fasting, and the transcription factor PPAR-alpha, and deacetylated/activated by SIRT3. (3) HMG-CoA lyase cleaves HMG-CoA into acetoacetate plus one acetyl-CoA. (4) Acetoacetate has two fates: it is reduced to D-beta-hydroxybutyrate by beta-hydroxybutyrate dehydrogenase (BDH1) using NADH — the more reduced the mitochondrion, the more BHB — or it spontaneously decarboxylates to acetone, which is exhaled.

Acetoacetate and beta-hydroxybutyrate leave the hepatocyte and circulate to peripheral tissues. In the brain, heart, and skeletal muscle, they enter cells on monocarboxylate transporters MCT1 and MCT2, and the process reverses: BDH1 oxidizes BHB back to acetoacetate, then SCOT (OXCT1) transfers CoA from succinyl-CoA to make acetoacetyl-CoA, which thiolase splits into two acetyl-CoA. These acetyl-CoA feed the citric acid cycle and drive oxidative phosphorylation. Because hepatocytes lack SCOT, only the peripheral tissues — never the liver — can burn the ketones the liver produces.

Ketosis vs diabetic ketoacidosis

Feature	Nutritional / fasting ketosis	Diabetic ketoacidosis (DKA)
Trigger	Fasting or low-carb diet	Insulin deficiency (usually type 1 diabetes)
Insulin present	Yes — low but restraining	No — essentially absent
Blood ketones	~0.5–3 mmol/L	>10–25 mmol/L
Blood pH	Normal (~7.35–7.45)	Acidotic (< 7.30, high anion gap)
Blood glucose	Normal or low	Usually high (> 250 mg/dL)
Regulation	Self-limiting (insulin caps it)	Runaway (nothing caps it)
Clinical state	Well, adapted	Emergency: dehydration, vomiting, Kussmaul breathing
Treatment	None needed	IV insulin, fluids, electrolytes (K⁺)

The three ketone bodies compared

Property	Acetoacetate	D-beta-hydroxybutyrate	Acetone
Chemistry	True ketone (β-keto acid)	Hydroxy acid (reduced)	Ketone (volatile)
Made by	HMG-CoA lyase	BDH1 (from acetoacetate)	Spontaneous decarboxylation
Abundance in blood	Lower	Highest (main species)	Trace
Usable as fuel	Yes	Yes (via reconversion)	No (waste)
Fate	Oxidized in peripheral tissue	Oxidized in peripheral tissue	Exhaled / excreted
Detected by nitroprusside strip	Yes	No	Yes (weakly)

Famous experiments and history

• Petters and the fruity smell (1857). The Bohemian physician Wilhelm Petters first isolated acetone from the urine of a patient dying of diabetic coma, linking the sweet breath of the dying diabetic to a chemical cause. Adolf Kussmaul described the deep, labored breathing of the same patients in 1874 — now called Kussmaul respiration, the lungs blowing off CO₂ to fight the acidosis.
• Embden and the liver as the ketone factory (early 1900s). Gustav Embden's perfusion experiments showed that the liver, and specifically its handling of fatty acids, produces ketone bodies, establishing the organ specificity that still defines the pathway.
• Wilder and the ketogenic diet (1921). Russell Wilder at the Mayo Clinic proposed mimicking the anti-seizure effect of fasting with a high-fat, very-low-carbohydrate diet, coining the term "ketogenic diet." It became the standard epilepsy therapy before modern anticonvulsants and remains in use for drug-resistant cases and for GLUT1 deficiency.
• Krebs, Lehninger, and Lynen map the biochemistry (1940s–1960s). The enzymatic steps — thiolase, HMG-CoA synthase, and HMG-CoA lyase — were worked out through the mid-twentieth century, with Feodor Lynen's work on acetyl-CoA and Fritz Lipmann's discovery of coenzyme A (Nobel Prize 1953) providing the chemical vocabulary of the pathway.
• Cahill's starvation studies (1960s–1970s). George Cahill fasted human volunteers and measured fuel fluxes across organs, showing that after about three weeks the brain shifts to using ketone bodies for roughly two-thirds of its energy, sharply reducing glucose demand and the muscle wasting of gluconeogenesis. Cahill's work turned ketones from a curiosity of diabetic urine into the central adaptation that lets a human survive prolonged fasting.